bluuebunny/crossref_metadata_2025_split huggingface dataset:
Are Malaysian Type 2 Diabetes patients willing to be trained to speak to their offspring about risk of diabetes and preventive measures?
Authors: Badlishah-Sham Siti Fatimah , Ramli Anis Safura , Isa Mohamad Rodi , Mohd-Zaki Nurzakiah , Whitford David Leonard 
Published: March 2020

Abstract
Background : Offspring of diabetes patients have an absolute risk of 20-40% of developing the condition. Diabetes patients should be encouraged to speak to their offspring regarding diabetes risk and prevention strategies. The Health Belief Model conceptualises that the higher the perceived risk, the more likely an individual will modify their behaviour. The objectives of this study were to i) determine the distribution of type 2 diabetes patients regarding their willingness to accept training to speak to their offspring, ii) determine the distribution of type 2 diabetes patients regarding their willingness to accept training based on the HBM and iii) to determine the factors associated with their willingness to accept training.
Methods : This was a cross-sectional study amongst type 2 diabetes patients attending two primary care clinics in Malaysia. Sociodemographic data and knowledge of diabetes risk factors were collected. The adapted, translated and validated Diabetes Mellitus in the Offspring Questionnaire-Malay version (DMOQ-Malay) was self-administered. Statistical analysis included descriptive statistics, univariate and multiple logistic regression.
Results : A total of 425 participants were recruited. Of these, 61.6% were willing to accept training. In MLogR, six variables were found to be significantly associated with willingness to accept training. These were i) positive family history [Adj. OR 2.06 (95% CI: 1.27, 3.35)], ii) having correct knowledge that being overweight is a risk factor [Adj. OR 1.49 (95%CI: 1.01, 2.29)], iii) correctly identifying age 40 years old as a risk factor [Adj. OR 1.88 (95%CI: 1.22, 2.90)], iv) agreeing that speaking to their offspring would help them to prevent type 2 diabetes [Adj. OR 4.34 (95%: 1.07, 17.73)], v) being neutral with the statement ‘I do not have much contact with my offspring’ [Adj. OR: 0.31 (95% CI: 0.12, 0.810] and vi) being neutral with the statement ‘my offspring are not open to advice from me’ [Adj. OR: 0.63 (95% CI: 0.31, 0.84].
Conclusion : The majority of type 2 diabetes patients were willing to accept training to speak to their offspring to prevent diabetes. A training module should be designed to enhance their knowledge, attitude and skills to become family health educators.
Achieving blood pressure control targets in hypertensive patients of rural China – A pilot randomized trial
Authors: Huang Xiao , Liu Lishun , Song Yun , Gao Lan , Zhao Min , Bao Huihui , Qin Xianhui , Wu Yanqing , Wu Qinghua , Bi Chonglei , Yue Aiping , Fang Chongqian , Ma Hai , Cui Yimin , Tang Genfu , Li Ping , Zhang Yan , Li Jianping , Wang Binyan , Xu Xiping , Wang Hong , Parati Gianfranco , Spence J. David , Wang Xiaobin , Huo Yong , Chen Guangliang , Cheng Xiaoshu 
Published: March 2020

Abstract
Background: This study aimed to test the feasibility and titration methods to achieve specific BP control targets in hypertensive patients of rural China. Methods: A randomized, controlled, open-label trial was conducted in Rongcheng, China. We enrolled 105 hypertensive participants aged over 60 years, and who had no history of stroke and cardiovascular disease. The patients were randomly assigned to one of three systolic BP target groups: standard: 140 - < 150mmHg; moderately intensive: 130 - < 140mmHg; and intensive: <130mmHg. Patients were followed for 6 months. Discussion: The optimal target for SBP lowering is still uncertain worldwide and such information is critically needed, especially in China. However, in China the rates of awareness, treatment and control are only 46.9%, 40.7% and 15.3%, respectively. It is challenging to achieve BP control in the real world and it is very important to develop population-specific BP control protocols that fully consider the population’s characteristics, such as age, sex, socio-economic status, compliance, education level and lifestyle. This randomized trial showed feasibility and safety of the titration protocol to achieve desirable SBP targets (<150, <140, and <130mmHg) in a sample of rural Chinese hypertensive patients. The three BP target groups had similar baseline characteristics. After 6 months of treatment, the mean SBP measured at an office visit was 137.2mmHg, 131.1mmHg, and 124.2mmHg in the three groups. Home BP and central aortic BP measurements were also obtained. At 6 months, home BP measurements (2 hours after drug administration) showed a mean SBP of 130.9 mmHg in the standard group, 124.9 mmHg in the moderately intense group, and 119.7 mmHg in the intensive group. No serious adverse events were recorded over the 6-month study period. Rates of adverse events including dry cough, palpitations, and arthralgia were low and showed no significant differences between the three groups. This trial gained real world experience and laid the foundation for a future large-scale BP target study.Trial registration: Feasibility Study of the Intensive Systolic Blood Pressure Control; ClinicalTrials.gov Identifier: NCT02817503. Registered 29 June 2016 - Retrospectively registered, https://www.clinicaltrials.gov/ct2/results?cond=&term=02817503&cntry=&state=&city=&dist=
An exploration of the experiences of professionals supporting patients approaching the end of life in medicines management at home. A qualitative study.
Authors: Wilson Eleanor , Caswell Glenys , Latif Asam , Anderson Claire , Faull Christina , Pollock Kristian 
Published: March 2020

Abstract

Background: The management of medicines towards the end of life can place increasing burdens and responsibilities on patients and families. This has received little attention yet can be a source of great difficulty and distress patients and families. Dose administration aids can be useful for some patients but there is no evidence for their wide spread use or the implications for their use as patients become increasing unwell. The study aimed to explore how healthcare professionals describe the support they provide for patients to manage medications at home at end of life.
Methods: Qualitative interview study with thematic analysis. Participants were a purposive sample of 40 community healthcare professionals (including GPs, pharmacists, and specialist palliative care and community nurses) from across two English counties.
Results: Healthcare professionals reported a variety of ways in which they tried to support patients to take medications as prescribed. While the paper presents some solutions and strategies reported by professional respondents it was clear from both professional and patient/family caregiver accounts in the wider study that rather few professionals provided this kind of support. Standard solutions offered included: rationalising the number of medications; providing different formulations; explaining what medications were for and how best to take them. Dose administration aids were also regularly provided, and while useful for some, they posed a number of practical difficulties for palliative care. More challenging circumstances such as substance misuse and memory loss required more innovative strategies such as supporting ways to record medication taking; balancing restricted access to controlled drugs and appropriate pain management and supporting patient choice in medication use.
Conclusions: The burdens and responsibilities of managing medicines at home for patients approaching the end of life has not been widely recognised or understood. This paper considers some of the strategies reported by professionals in the study, and points to the great potential for a more widely proactive stance in supporting patients and family carers to understand and take their medicines effectively. By adopting tailored, and sometimes, ‘outside the box’ thinking professionals can identify immediate, simple solutions to the problems patients and families experience with managing medicines.
Treatment with radiosynoviorthesis in hemophilic patients with and without inhibitor
Authors: Sanabria Mario Edgar Tena , Sato Y. Rojas , Resendiz J.C Castañeda , Herrera G. Fuentes , González Yureni Irani Tena , Ne Juan Carlos Núñez Enríquez , Ne Félix Alejandro Álvarez Martínez 
Published: March 2020

Abstract
Background. Spontaneous bleedings occurring into joints (hemarthrosis) are the most common manifestations of hemophilia and causes severe joint damage ultimately resulting in joint disfunction known as hemophilic arthropathy. Among available therapeutic options for reducing recurrent hemarthrosis-associated damage, radiosynoviorthesis (RS) has proven effective in improving joint function. Aim. To assess the impact of RS with Yttrium(90) citrate (C-Y(90)) on frequency of hemarthroses, need for prophylaxis and joint function in a group of pediatric patients. Methods. Between November 1998 and February 2017, we evaluated 27 pediatric patients with mild, moderate or severe hemophilia with haemophilic arthropathy. Overall, RS was applied in 60 joints. Some patients received more than one single intra-articular injection with C-Y(90). Results. During the follow-up, one patient showed joint bleeding 15 months after RS, one patient after 12 months and one patient after 45 days. The need for prophylaxis was reduced and joint function significantly improved in all patients. Conclusion. RS with C-Y(90) is a simple and safe treatment for reducing the frequency of hemarthroses in patients with hemophilia. It decreases the use of factor VIII / IX and improves joint function.
Machine learning prediction of oncology drug targets based on protein and network properties
Authors: Dezso Zoltan , Ceccarelli Michele 
Published: March 2020

Abstract
Background
The selection and prioritization of drug targets is a central problem in drug discovery. Computational approaches can leverage the growing number of large-scale human genomics and proteomics data to make in-silico target identification, reducing the cost and the time needed.
Results
We developed a machine learning approach to score proteins to generate a druggability score of novel targets. In our model we incorporated 70 protein features which included properties derived from the sequence, features characterizing protein functions as well as network properties derived from the protein-protein interaction network. The advantage of this approach is that it is unbiased and even less studied proteins with limited information about their function can score well as most of the features are independent of the accumulated literature. We build models on a training set which consist of targets with approved drugs and a negative set of non-drug targets. The machine learning techniques help to identify the most important combination of features differentiating validated targets from non-targets. We validated our predictions on an independent set of clinical trial drug targets, achieving a high accuracy characterized by an AUC of 0.89. Our most predictive features included biological function of proteins, network centrality measures, protein essentiality, tissue specificity, localization and solvent accessibility. Our predictions, based on a small set of 102 validated oncology targets, recovered the majority of known drug targets and identifies a novel set of proteins as drug target candidates.
Conclusions
We developed a machine learning approach to prioritize proteins according to their similarity to approved drug targets. We have shown that the method proposed is highly predictive on a validation dataset consisting of 277 targets of clinical trial drug confirming that our computational approach is an efficient and cost-effective tool for drug target discovery and prioritization. Our predictions were based on oncology targets and cancer relevant biological functions, resulting in significantly higher scores for targets of oncology clinical trial drugs compared to the scores of targets of trial drugs for other indications. Our approach can be used to make indication specific drug-target prediction by combining generic druggability features with indication specific biological functions.
Use of peripheral vascular access in the prehospital setting: is there room for improvement?
Authors: Gonvers Erin , Spichiger Thierry , Albrecht Eric , Dami Fabrice 
Published: March 2020

Abstract
Background: Previous studies have shown that prehospital-insertion of peripheral vascular access is highly variable. The aim of this study is to establish the proportion of peripheral vascular access placement and its use with regard to both the severity of cases and the main problem suspected by the paramedics involved. Over-triage was considered to have taken place where peripheral vascular access was placed but unused and these cases were specifically analysed in order to evaluate the possibility of improving current practice. Methods: This is a one-year retrospective study conducted throughout one state of Switzerland. Data were extracted from the state’s public health service database, collected electronically by paramedics on RescueNet® from Siemens. The following data were collected and analyzed: sex, age, main diagnosis suspected by paramedics and the National Advisory Committee for Aeronautics score (NACA) to classify the severity of cases. Results: A total of 33 055 missions were included, 29 307 (88.7%) with a low severity. A peripheral vascular access was placed in 8 603 (26.0%) cases, of which 5 678 (66.0%) were in patients with low severity. In 3 948 (45.9%) cases peripheral vascular access was set but unused with 2 626 (66.5%) of these cases being patients with low severity. Opiates represent 48.3% of all medications given. The most frequent diagnosis among unused peripheral vascular access were: respiratory distress (12.7%), neurological deficit without coma or trauma (9.6%), cardiac condition with thoracic pain and without trauma or loss of consciousness (9.6%) and decreased general condition of the patient (8.5%). Conclusions: Peripheral vascular access was set in 26% of patients, nearly half of which were unused. To reduce over-triage, special attention should be dedicated to cases defined by EMS on site as low severity, as they do not require placement of a peripheral vascular access as a precautionary measure. Alternative routes, such as the intra-nasal route, should be promoted, particularly for analgesia, whose efficiency is well documented. Emergency medical services medical directors may also consider modifying protocols of acute clinical situations when data show that mandatory peripheral vascular access, in stroke cases for example, is almost never used.
The diagnostic yield of intellectual disability: Combined whole genome low-coverage sequencing and medical exome sequencing
Authors: Wang Jun , Wang Yan , Wang Liwen , Chen Wangyang 
Published: March 2020

Abstract
Background: Intellectual disability (ID) is a heterogeneous neurodevelopmental disorder with a complex genetic underpinning in its etiology. Chromosome microarray (CMA) is recommended as the first-tier diagnostic test for ID due to high detection rate of copy number variation (CNV). Methods: To identify an appropriate clinical detection scheme for ID in Han Chinese patients, a whole genome low-coverage sequencing was performed as the first-tier diagnostic test, followed by medical exome sequencing as the second-tier diagnostic test for those patients with negative results of CNVs. Results: A total of 19 pathogenic CNVs in 16/95(16.84%) ID patients and 11 pathogenic single-nucleotide variations, including 7 novel mutations in 9/79(11.39%) ID patients were identified on whom no pathogenic CNVs were discovered. The detection rate of CNVs in ID s with multiple congenital anomalies (MCA) subgroup was significantly higher than ID s with autism spectrum disorder and the other IDs subgroup. Also single-nucleotide variations showed a higher occurrence rate in the other IDs subgroup. Conclusions: There were differences in the diagnostic yields of different variation types among the three ID subgroups. Our findings provided a new perspective on appropriate clinical detection scheme for different ID subgroups based on the statistical results of different ID subgroups. The application of whole genome low-coverage sequencing as the first-tier diagnostic test for ID with MCA subgroup and medical exome sequencing as the first-tier diagnostic test for other IDs subgroup were considered as an efficient clinical detection schemes.
COX5A over-expression protects cortical neurons from hypoxic ischemic injury in neonatal rats associated with TPI up-regulation
Authors: Jiang Ya , Bai Xue , Li Ting-Ting , Hawwas Mohammed AL , Jin Yuan , Zou Yu , Hu Yue , Liu Lin-Yi , Zhang Ying , Liu Qing , Yang Hao , Ma Jun , Wang Tinghua , Liu Jia , Xiong Liu-Lin 
Published: March 2020

Abstract
Background: Neonatal hypoxic-ischemic encephalopathy (HIE) represents as a major cause of neonatal morbidity and mortality. However, the underlying molecular mechanisms in brain damage are still not fully elucidated. This study was conducted to determine the specific potential molecular mechanism in the hypoxic-ischemic induced cerebral injury.
Methods: Here, hypoxic-ischemic (HI) animal models were established and primary cortical neurons were subjected to oxygen-glucose deprivation (OGD) to mimic HIE model in-vivo and in - vitro . The HI-induced neurological injury was evaluated by Zea-longa scores, Triphenyte-trazoliumchloride (TTC) staining the Terminal Deoxynucleotidyl Transferased Utp Nick End Labeling (TUNEL) and immunofluorescent staining. Then the expression of Cytochrome c oxidase subunit 5a (COX5A) was determined by immunohistochemistry, western blotting (WB) and quantitative real time Polymerase Chain Reaction (qRT-PCR) techniques. Moreover, HSV-mediated COX5A over-expression virus was transducted into OGD neurons to explore the role of COX5A in - vitro , and the underlying mechanism was predicted by GeneMANIA, then verified by WB and qRT-PCR.
Results: HI induced a severe neurological dysfunction, brain infarction, and cell apoptosis as well as obvious neuron loss in neonatal rats, in corresponding to the decrease on the expression of COX5A in both sides of the brain . What’s more, COX5A over-expression significantly promoted the neuronal survival, reduced the apoptosis rate, and markedly increased the neurites length after OGD. Moreover, Triosephosephate isomerase (TPI) was predicted as physical interactions with COX5A, and COX5A over-expression largely increased the expressional level of TPI.
Conclusions: The present findings suggest that COX5A plays an important role in promoting neurological recovery after HI, and this process is related to TPI up-regulation.
Juvenile diet quality and intensity of sexual conflict in the mite Sancassania berlesei
Authors: Łukasiewicz Aleksandra 
Published: March 2020

Abstract
Background

Differing evolutionary interests of males and females may result in sexual conflict, whereby traits or behaviours that are beneficial for male reproductive success (e.g., traits related to male-male competition) are costly for females. Since sexual conflict plays an important role in areas such as speciation, population persistence or evolution of life history traits, understanding what factors modulate the intensity of sexual conflict is important. This study aims to examine juvenile diet quality as one of the underestimated ecological factors that may affect the intensity of sexual conflict via individual conditions. I used food manipulation during the development of the mite Sancassania berlesei to investigate the effects on male reproductive behaviour and competitiveness, male-induced harm to female fitness and female resistance to this harm.

Results

Males that were exposed to low-quality food started mating later than the control males, and number of their mating attempts were decreased compared to those of control males. Moreover, males from the low-quality diet treatment sired fewer offspring in a competitive situation than males from the control treatment. However, the fitness of females exposed to males reared on a poor diet did not differ from that of females mated with control males. Furthermore, female diet quality did not alter their resistance to male-induced harm.

Conclusion

Overall, diet quality manipulation affected male reproductive behaviour and mating success. However, I found no evidence that the intensity of sexual conflict in S. berlesei depends on male or female conditions. Investigating a broad range of environmental factors will provide a better understanding of sexual conflict dynamics and its feedback into associated evolutionary mechanisms.
Predictive Value of Circulating Plasma Mitochondrial DNA for Sepsis in the Emergency Department: Observational Study Based on the Sepsis-3 Definition.
Authors: Wang Li feng , Zhou Wei , Wang Kai wen , He Shuang jun , Chen Yi 
Published: March 2020

Abstract
Background: The definition of sepsis is regularly updated; however, there is no standard diagnostic test. To improve diagnosis and prognostic prediction, the aim of this study was to determine the predictive value of circulating plasma mitochondrial DNA (mtDNA) levels in patients admitted to the emergency department (ED) with sepsis. Methods: A total of 107 patients hospitalized from June 2018 to January 2019 were divided into the sepsis (n = 72) and septic shock (n = 35) groups based on the sepsis-3 definition. Clinical and laboratory data were measured within 24 h of admission. The mtDNA concentrations in clarified plasma were estimated by quantitative polymerase chain reaction. Binary logistic regression analysis and the receiver operating characteristic (ROC) curve were used to determine predictive value of mtDNA and other markers for sepsis outcome (28-day mortality).Results: The median plasma mtDNA levels on admission were significantly higher in the septic shock patients than in the sepsis patients (P < 0.0 1), and were also higher in non-survivors than in survivors within 28 days (P < 0.01). Binary logistic regression showed that plasma lactate and mtDNA levels were independent risk factors for 28-day mortality [odds ratio (OR) 1.341, 95% confidence interval (CI) 1.035–1.736, P = 0.026 and OR 13.299, 95%CI 2.765–63.956, P = 0.001, respectively).The area under the ROC curve values for plasma mtDNA levels, lactate concentration, and their combined were 0.781 (p < 0.001, 95%CI 0.671–0.891), 0.733 (p < 0.001, 95%CI 0.635–0.832), and 0.799 (p < 0.001, 95%CI 0.698–0.901), respectively. The calibration test for the combined variable showed X 2 of 2.559 and P = 0.923. Conclusion: A higher plasma mtDNA level was associated with a poor prognosis of sepsis in the emergency room, and was a superior predictor to lactate for predicting 28-day mortality.